` BIOL (BIOLASE Inc) vs S&P 500 Comparison - Alpha Spread

BIOL
vs
S&P 500

Over the past 12 months, BIOL has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.

Stocks Performance
BIOL vs S&P 500

Loading
BIOL
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BIOL vs S&P 500

Loading
BIOL
S&P 500
Difference
www.alphaspread.com

Performance By Year
BIOL vs S&P 500

Loading
BIOL
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
BIOLASE Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

BIOLASE Inc
Glance View

Market Cap
260k USD
Industry
Health Care

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. The company is headquartered in Foothill Ranch, California and currently employs 158 full-time employees. The firm develops, manufactures, markets and sells laser systems, which provides helps to dental practitioners and their patients. The Company’s systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. Its Waterlase brand uses a patented combination of water and laser energy and performs using drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. The company offers its diode laser systems to perform soft tissue, pain therapy and cosmetic procedures, including teeth whitening. The company has approximately 301 issued and 38 pending United States and international patents.

BIOL Intrinsic Value
Not Available
Back to Top